Spectrum Pharmaceuticals and Allos Therapeutics, Inc. Company Profile
Spectrum Pharmaceuticals, a biotechnology company with a primary focus in oncology and hematology, currently markets two oncology drugs, FUSILEV® and ZEVALIN®. In addition, Spectrum has two drugs, apaziquone and belinostat, in late stage development. Spectrum also has a diversified pipeline of novel drug candidates. Spectrum’s strategy is comprised of acquiring, developing and commercializing a broad and diverse pipeline of late-stage clinical and commercial drug products. Spectrum has aggressive business development and commercial operation teams that support a robust drug development program encompassing clinical development, medical research, regulatory affairs, biostatistics and data management. Spectrum also leverages the expertise of its worldwide partners to assist in the execution of its strategy. For more information, please visit Spectrum’s website at www.sppirx.com.
News Articles
Spectrum completes deal for Allos Therapeutics
Spectrum Pharmaceuticals Inc. said Thursday it completed its acquisition of Allos Therapeutics Inc., giving the combined company a third approved drug.Spectrum said 90 percent of Allos' shares were t...
Spectrum Pharmaceuticals Completes Acquisition of Allos Therapeutics
Spectrum Pharmaceuticals (Henderson, NV), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology today announced the s...
U.S. approves Spectrum Pharma's purchase of Allos
WASHINGTON (Reuters) - U.S. antitrust officials have approved Spectrum Pharmaceuticals' purchase of cancer drugmaker Allos Therapeutics, a $206 million deal aimed at giving Spectrum access to the Allo...
FTC clears Spectrum's $206M buyout of Allos
The Federal Trade Commission gave Spectrum Pharmaceuticals approval to acquire oncological drugmaker Allos Therapeutics for $ -More-
Spectrum extends tender offer for Allos
US biotech firm Spectrum Pharmaceuticals (Nasdaq: SPPI) said late Friday that it has again extended tender offer to purchase all of the outstanding shares of common stock of Allos Therapeutics (Nasdaq...
Spectrum extends tender offer for shares of Allos Therapeutics
Spectrum Pharmaceuticals, a biotech with a primary focus in oncology and hematology, has extended the offer period for its tender offer to purchase all of the outstanding shares of common stock of All...
Spectrum closes acquisition of Allos Therapeutics
Spectrum Pharmaceuticals finalized its purchase of Allos Therapeutics for $194.1 million. -More- FDA Oks Prostate Cancer Drug 3 Months Ahead of PDUFA Date San Francisco-based Medivation Inc...
Spectrum again extends its buyout bid for Allos
Spectrum Pharmaceuticals is extending for the fourth time its $1.82-per-share bid to acquire all outstanding shares of Allos -More-
Drugs and Medications
Neutrogena mineral sheers [Neutrogena Corporation]
Neutrogena Mineral Sheers Loose Powder SPF 20
Solar sense zany zinc spf 50 - white [CCA Industries, Inc. ]
SOLAR SENSE ZANY ZINC SPF 50 - WHITE
Solar sense zany zinc spf 50 - green [CCA Industries, Inc. ]
SOLAR SENSE ZANY ZINC SPF 50 - GREEN
Sk1n natural sunscreen spf 40 [True Nature Group, Inc.]
Drug Facts
PubMed Articles
The Bipolar Spectrum: Myth or Reality?
The idea of a "bipolar spectrum" is controversial due to 1) lack of widely accepted definitions, 2) concern that spectrum definitions might subsume cases with non-bipolar disorders, 3) worry that "dia...
The term autism spectrum disorder refers to a constellation of symptoms involving impairments in social interaction and communication, and restricted, repetitive behaviours and interests. This article...
Terahertz spectrum analyzer based on frequency and power measurement.
We demonstrate a terahertz (THz) spectrum analyzer based on frequency and power measurement. A power spectrum of a continuous THz wave is measured through optical heterodyne detection using an electro...
Detection of explosives based on surface-enhanced Raman spectroscopy.
In this study we present a device based on surface-enhanced Raman scattering (SERS) for the detection of airborne explosives. The explosives are resublimated on a cooled nanostructured gold substrate....
Spectrum reconstruction based on the constrained optimal linear inverse methods.
The dispersion effect of birefringent material results in spectrally varying Nyquist frequency for the Fourier transform spectrometer based on birefringent prism. Correct spectral information cannot b...
Clinical Trials
Phenotypic and Genetic Factors in Autism Spectrum Disorders
The purpose of the study is to collect phenotypic (observable characteristics) and genetic information about individuals with Autism Spectrum Disorders (ASDs) and their families.
Structural and Functional Connectivity in Autism Spectrum Disorders
Autism spectrum disorder (ASD) has been given a high priority for genetic and neurobiological study. There is no such information in Asian population and no study has conducted using Diffu...
Functional MRI Evaluation of the Effect of Citalopram in Autism Spectrum Disorders
The purpose of this study is to use functional magnetic resonance imaging and behavioral assessments to investigate the effect of citalopram on restricted repetitive behaviors in people wi...
Effect of Cognitive Behavioural Therapy (CBT) for Children With Autistic Spectrum Disorders
Cognitive Behavioural Therapy is an effective intervention program for children with High-Functioning Autistic Spectrum Disorder to remediate anxiety issues.
A Randomized Clinical Trial for Toddlers With ASD
This research is being done to test the effectiveness of two treatments aimed at increasing language and social skills in children with autism spectrum disorder. If children show improveme...
Companies
Allos Therapeutics, Inc. (Nasdaq: ALTH) is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. Allos is currentl...
Allos Therapeutics Incorporated
Allos Therapeutics is a biopharmaceutical company focused on developing and commercializing innovative drugs for improving cancer treatments. Since 1994, we have been committed to improving the health...
Spectrum Pharmaceuticals and Allos Therapeutics, Inc.
Spectrum Pharmaceuticals, a biotechnology company with a primary focus in oncology and hematology, currently markets two oncology drugs, FUSILEV® and ZEVALIN®. In addition,...
Spectrum is the leader of organizations that provide physicians, clinical personnel, and management services to military treatment facilities (MTFs) throughout the United States. Spectrum serves 126 M...
Spectrum Bridge, Inc. (SBI) delivers software and services to wireless service providers and equipment manufacturers. SBI enables wireless networks to access and use all types of...
More Information about "Spectrum Pharmaceuticals and Allos Therapeutics, Inc." on BioPortfolio
We have published hundreds of Spectrum Pharmaceuticals and Allos Therapeutics, Inc. news stories on BioPortfolio along with dozens of Spectrum Pharmaceuticals and Allos Therapeutics, Inc. Clinical Trials and PubMed Articles about Spectrum Pharmaceuticals and Allos Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Spectrum Pharmaceuticals and Allos Therapeutics, Inc. Companies in our database. You can also find out about relevant Spectrum Pharmaceuticals and Allos Therapeutics, Inc. Drugs and Medications on this site too.
